Y-MABS THERAPEUTICS, INC.
INVENTION AND CONFIDENTIAL INFORMATION AGREEMENT
In consideration of my employment or continued employment by Y-mAbs Therapeutics, Inc. (the “Company”), and the compensation now and hereafter paid to the undersigned, the undersigned, hereby agree as follows:
1. Nondisclosure.
1.1 Recognition of Company’s Rights; Nondisclosure. At all times during my employment and thereafter, I will hold in strictest confidence and will not disclose, use, lecture upon or publish any of the Company’s Confidential Information (defined below), except as such disclosure, use or publication may be required in connection with my work for the Company, or unless an executive officer of the Company expressly authorizes such in writing. I will obtain Company’s written approval before publishing or submitting for publication any material (written, verbal, or otherwise) that relates to my work at Company and/or incorporates any Confidential Information. I hereby assign to the Company any rights I may have or acquire in such Confidential Information and recognize that all Confidential Information shall be the sole property of the Company and its assigns.
1.2 Confidential Information. The term “Confidential Information” shall mean any and all confidential and/or proprietary knowledge, data or information (in any format, whether written, visual, oral, electronic or otherwise, and irrespective of the form of communication and whether furnished before, on or after the date hereof) of or concerning the Company, its Affiliates, its partners, customers and suppliers. By way of illustration but not limitation, the term “Confidential Information” includes (a) data, results, targets, ideas, processes, techniques, formulae, know-how, improvements, discoveries, developments and designs, tangible and intangible information relating to biological materials such as cell lines, antibodies, tissue samples, proteins, nucleic acids and the like, assays and assay components and media, procedures and formulations for producing any such assays or assay components, and pre-clinical and clinical data, results, developments or experiments (hereinafter collectively referred to as “Inventions”), (b) plans for research, development and new products, manufacturing, marketing and selling information, business plans, budgets and unpublished financial statements, licenses, prices and costs, (c) information regarding the skills and compensation of other employees of the Company, and (d) financial data, customer data, product descriptions, potential product development ideas, database descriptions, business workflow, and business information (including, without limitation, computer programs, software, databases, names and expertise of employees, suppliers, and consultants, customer lists and information, models, algorithms, know-how, formulas, processes, ideas, inventions (whether patentable or not), schematics and other technical, business, financial, customer and product development plans, forecasts, strategies and information, which are confidential, nonpublic, competitively sensitive, private, and/or proprietary and including all analyses, compilations, forecasts, data, studies, notes, translations, memoranda, copies thereof or other documents or materials prepared therefrom by the Company, its Affiliates, its partners, customers and suppliers or their respective Representatives.
For the purposes of this Agreement, the terms set forth below shall have the following meanings:
(i) “Affiliate” shall mean, as to any person, any other person that, directly or indirectly, is in control of, is controlled by, or is under common control with, such person, and “control” means, with respect to any person, the possession, direct or indirect, of the power to direct or cause the direction of the management or policies of such person;
(ii) “person” shall be broadly interpreted to include, without limitation, the media, any governmental representative, any corporation, company, partnership, joint venture, group, limited liability company, or other entity or individual; and
(iii) “Representative” shall mean, as to any person, its directors, officers, partners, associates, employees, agents, independent contractors, consultants and advisors (including, without limitation, financial advisors, bankers, attorneys and accountants);
1.3 Third Party Information. I understand, in addition, that the Company has received and in the future will receive from third parties confidential or proprietary information (“Third Party Information”)